User:Apolena Zounarová/Sandbox 2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 22: Line 22:
T-cell-acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic tumor that predominantly affects children and adolescents. T-ALL is more prevalent in males. T-ALL is manifested by malignant differentiation of the multipotent precursor cells of the lymphoid lineage which lost their ability to mature and became the leukemic blasts infiltrating bone marrow. T-ALL overall has a poor prognosis, 5-year relapse-free survival rate is over 75 % in children and 50 % in adults <ref name="pui">DOI 10.1016/S0140-6736(08)60457-2</ref>.
T-cell-acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic tumor that predominantly affects children and adolescents. T-ALL is more prevalent in males. T-ALL is manifested by malignant differentiation of the multipotent precursor cells of the lymphoid lineage which lost their ability to mature and became the leukemic blasts infiltrating bone marrow. T-ALL overall has a poor prognosis, 5-year relapse-free survival rate is over 75 % in children and 50 % in adults <ref name="pui">DOI 10.1016/S0140-6736(08)60457-2</ref>.
The importance of Notch1 mutations in T-ALL has been shown by Weng and colleagues <ref name="weng">DOI 10.1126/science.1102160</ref>. 44 % of Notch-dependent T-ALL cell lines harboured gain-of-function mutations in the heterodimerization domain. Moreover, about 40 % of these cases were accompanied by mutations in the intracellular PEST domain of Notch1 which is important for the signal termination <ref name="sundaram">PMID: 8293978</ref>. Weng and colleagues proposed a model of synergy in which mutations in the heterodimerization domain increase the production of NICD by γ-secretase cleavage while mutations in intracellular PEST domain increases its half-life. Cell lines with mutations in the heterodimerization domain are sensitive to γ-secretase inhibitors and exhibit G0/G1 cell cycle arrest opposed to PEST domain mutants which are unaffected by the inhibitor <ref name="weng" />. Common mutations found in human T-ALL and acting in γ-secretase-dependent manner are L1575P, L1594P, and L1601P <ref name="malecki">DOI 10.1128/MCB.01655-05</ref><ref name="weng" />.
The importance of Notch1 mutations in T-ALL has been shown by Weng and colleagues <ref name="weng">DOI 10.1126/science.1102160</ref>. 44 % of Notch-dependent T-ALL cell lines harboured gain-of-function mutations in the heterodimerization domain. Moreover, about 40 % of these cases were accompanied by mutations in the intracellular PEST domain of Notch1 which is important for the signal termination <ref name="sundaram">PMID: 8293978</ref>. Weng and colleagues proposed a model of synergy in which mutations in the heterodimerization domain increase the production of NICD by γ-secretase cleavage while mutations in intracellular PEST domain increases its half-life. Cell lines with mutations in the heterodimerization domain are sensitive to γ-secretase inhibitors and exhibit G0/G1 cell cycle arrest opposed to PEST domain mutants which are unaffected by the inhibitor <ref name="weng" />. Common mutations found in human T-ALL and acting in γ-secretase-dependent manner are L1575P, L1594P, and L1601P <ref name="malecki">DOI 10.1128/MCB.01655-05</ref><ref name="weng" />.
 +
 +
===Mutations in Heterodimerization Domain===
 +
Activating mutations in the heterodimerization domain are predominantly missense mutations at sites which are conserved among vertebrate Notch receptors or small in-frame insertions and deletions. As a consequence, mutated receptors are activated regardless of the binding of a ligand <ref name="malecki" /><ref name="weng" />. The mutation hotspot is the region between residues 1574 and 1622 of the N-terminal portion of the heterodimerization domain which contains several highly conserved hydrophobic residues including a cluster of aliphatic amino acids. In this region are located activating mutations such as L1575P, L1594P, or L1601P which can increase the transcription from 3- to 9-fold <ref name="weng" />. However, some similar missense mutations in invariant amino acids can be also found in the C-terminal part of the heterodimerization domain <ref name="malecki" /><ref name="weng" />. Abovementioned mutations cause heterodimers to dissociate more readily. Among the mutations with the strongest effect on the heterodimer dissociation are L1601P, V1677D, and L1679P which induce dissociation of most or almost all furin-processed heterodimers into two subunits <ref name="malecki" />. The position of these mutations can be explained from the structural properties of interacting chains which are forming antiparallel beta sheets. Especially in case of a strong secondary structure breaker such as proline, this interaction can be impaired <ref name="pdb3i08">DOI 10.2210/pdb3I08/pdb</ref>. Besides that, Notch can be also activated by insertions. One mutation identified by Malecki and colleagues was a 16 amino acid long insertion which had negligible effect on heterodimer stability, but probably changed the relative position of S2 site in respect to the protective part of Notch <ref name="malecki" />.
 +
 +
Aberrant proteolytic processing can be also triggered by changes in spacing of the heterodimerization domain from the plasma membrane. These mutations are called juxtamembrane expansion (JME) alleles. These mutations are duplication insertions in the vicinity of the extracellular juxtamembrane region of the receptor and they depend more on the size of insertion than on the specific amino acid sequence. Insertions are clustered around position 1740 and range from 11 to 36 amino acids <ref name="sulis">DOI 10.1182/BLOOD-2007-12-130096</ref>.
 +
Some of the mutations such as L1601P and F1593S can affect furin cleavage. This might be caused by a retention of newly synthesised Notch in endoplasmic reticulum due to possible changes in folding, and recognition by ER-resident quality control mechanism <ref name="malecki" />.
 +
== Relevance ==
== Relevance ==

Revision as of 17:09, 27 April 2022

Notch1 Heterodimerization Domain in T-cell Acute Lymphoblastic Leukaemia

Notch1 Heterodimerization Domain. Juxtamembrane peptide containing the S2 site in green, negative regulatory domain in blue.

Drag the structure with the mouse to rotate

References

  1. Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol. 2008;3:587-613. doi:, 10.1146/annurev.pathmechdis.3.121806.154300. PMID:18039126 doi:http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154300
  2. 2.0 2.1 Gordon WR, Vardar-Ulu D, L'Heureux S, Ashworth T, Malecki MJ, Sanchez-Irizarry C, McArthur DG, Histen G, Mitchell JL, Aster JC, Blacklow SC. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2. PLoS One. 2009 Aug 24;4(8):e6613. PMID:19701457 doi:10.1371/journal.pone.0006613
  3. 3.0 3.1 3.2 . UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489. doi: 10.1093/nar/gkaa1100. PMID:33237286 doi:http://dx.doi.org/10.1093/nar/gkaa1100
  4. 4.0 4.1 4.2 Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israel A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000 Feb;5(2):207-16. doi: 10.1016/s1097-2765(00)80417-7. PMID:10882063 doi:http://dx.doi.org/10.1016/s1097-2765(00)80417-7
  5. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell. 2000 Feb;5(2):197-206. doi: 10.1016/s1097-2765(00)80416-5. PMID:10882062 doi:http://dx.doi.org/10.1016/s1097-2765(00)80416-5
  6. Nichols JT, Miyamoto A, Olsen SL, D'Souza B, Yao C, Weinmaster G. DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J Cell Biol. 2007 Feb 12;176(4):445-58. doi: 10.1083/jcb.200609014. PMID:17296795 doi:http://dx.doi.org/10.1083/jcb.200609014
  7. 7.0 7.1 De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999 Apr 8;398(6727):518-22. doi: 10.1038/19083. PMID:10206645 doi:http://dx.doi.org/10.1038/19083
  8. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998 May 28;393(6683):382-6. doi: 10.1038/30756. PMID:9620803 doi:http://dx.doi.org/10.1038/30756
  9. Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol. 2004 Nov;24(21):9265-73. doi: 10.1128/MCB.24.21.9265-9273.2004. PMID:15485896 doi:http://dx.doi.org/10.1128/MCB.24.21.9265-9273.2004
  10. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1683-8. doi: 10.1073/pnas.93.4.1683. PMID:8643690 doi:http://dx.doi.org/10.1073/pnas.93.4.1683
  11. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008 Mar 22;371(9617):1030-43. doi: 10.1016/S0140-6736(08)60457-2. PMID:18358930 doi:http://dx.doi.org/10.1016/S0140-6736(08)60457-2
  12. 12.0 12.1 12.2 12.3 12.4 12.5 Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004 Oct 8;306(5694):269-71. doi: 10.1126/science.1102160. PMID:15472075 doi:http://dx.doi.org/10.1126/science.1102160
  13. Sundaram M, Greenwald I. Suppressors of a lin-12 hypomorph define genes that interact with both lin-12 and glp-1 in Caenorhabditis elegans. Genetics. 1993 Nov;135(3):765-83. PMID:8293978
  14. 14.0 14.1 14.2 14.3 14.4 14.5 Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC, Blacklow SC. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol. 2006 Jun;26(12):4642-51. doi: 10.1128/MCB.01655-05. PMID:16738328 doi:http://dx.doi.org/10.1128/MCB.01655-05
  15. doi: https://dx.doi.org/10.2210/pdb3I08/pdb
  16. Sulis ML, Williams O, Palomero T, Tosello V, Pallikuppam S, Real PJ, Barnes K, Zuurbier L, Meijerink JP, Ferrando AA. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood. 2008 Aug 1;112(3):733-40. doi: 10.1182/blood-2007-12-130096. Epub 2008 Apr, 14. PMID:18411416 doi:http://dx.doi.org/10.1182/blood-2007-12-130096
  17. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  18. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644

Proteopedia Page Contributors and Editors (what is this?)

Apolena Zounarová

Personal tools